107 related articles for article (PubMed ID: 3453392)
1. Angiotensin II potentiates the vasoconstrictive effect of norepinephrine in normotensive and hypertensive man.
Reams GP; Bauer JH
J Clin Hypertens; 1987 Dec; 3(4):610-6. PubMed ID: 3453392
[TBL] [Abstract][Full Text] [Related]
2. Morphology of resistance arteries and comparison of effects of vasoconstrictors in mild essential hypertensive patients.
Schiffrin EL; Deng LY; Larochelle P
Clin Invest Med; 1993 Jun; 16(3):177-86. PubMed ID: 8365045
[TBL] [Abstract][Full Text] [Related]
3. Interrelationship between subpressor effects of vasopressin and other vasoactive hormones in the rat.
Ishikawa S; Goldberg JP; Schrier DM; Aisenbrey GA; Schrier RW
Miner Electrolyte Metab; 1984; 10(3):184-9. PubMed ID: 6328239
[TBL] [Abstract][Full Text] [Related]
4. Subpressor doses of angiotensin II do not increase albumin excretion in humans.
Erley CM; Grau C; Furian TC; Wolf S; Braun N; Risler T
Clin Nephrol; 1996 Nov; 46(5):312-8. PubMed ID: 8953120
[TBL] [Abstract][Full Text] [Related]
5. On the vascular reactivity to angiotensin and noradrenaline in normotensive and spontaneously hypertensive rats.
Somova LI
Acta Physiol Pharmacol Bulg; 1983; 9(1):51-8. PubMed ID: 6624492
[TBL] [Abstract][Full Text] [Related]
6. Calf muscle haemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with a familial predisposition to hypertension: changes during increased salt intake.
Gudmundsson O; Andersson OK; Aurell M; Wikstrand JM; Berglund GL
J Hypertens; 1984 Jun; 2(3):291-6. PubMed ID: 6397530
[TBL] [Abstract][Full Text] [Related]
7. Enhanced angiotensin-mediated facilitation of adrenergic neurotransmission in spontaneously hypertensive rats.
Kawasaki H; Cline WH; Su C
J Pharmacol Exp Ther; 1982 Apr; 221(1):112-6. PubMed ID: 6278133
[TBL] [Abstract][Full Text] [Related]
8. Vascular structure enhances regional resistance responses in mild essential hypertension.
Egan B; Schork N; Panis R; Hinderliter A
J Hypertens; 1988 Jan; 6(1):41-8. PubMed ID: 3351293
[TBL] [Abstract][Full Text] [Related]
9. Quinapril ACE-inhibition effects on adrenergic parameters in moderate essential hypertension.
Vallès Prats M; Matas Serra M; Bronsoms Artero J; Matè Benito G; Torguet Escuder P; Mauri Nicolas JM
Kidney Int Suppl; 1996 Jun; 55():S104-6. PubMed ID: 8743525
[TBL] [Abstract][Full Text] [Related]
10. [Role of nitric oxide in the modulation of the vascular response to angiotensin II in hypertensive rats].
Sánchez Mendoza A; Vázquez Cruz B; Escalante Acosta BA
Arch Inst Cardiol Mex; 1996; 66(4):306-12. PubMed ID: 8984951
[TBL] [Abstract][Full Text] [Related]
11. The interaction between noradrenaline and angiotensin II in man: evidence for a postsynaptic and against a presynaptic interaction.
Seidelin PH; Coutie WJ; Pai MS; Morton JJ; Struthers AD
J Hypertens Suppl; 1987 Dec; 5(5):S121-4. PubMed ID: 3481814
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure.
Brooks DP; Ruffolo RR
J Hypertens Suppl; 1999 Jun; 17(2):S27-32. PubMed ID: 10465064
[TBL] [Abstract][Full Text] [Related]
13. Dietary salt intake, blood pressure and the kidney in hypertensive patients with non-insulin dependent diabetes mellitus.
Campese VM; Wurgaft A; Safa M; Bianchi S
J Nephrol; 1998; 11(6):289-95. PubMed ID: 10048494
[TBL] [Abstract][Full Text] [Related]
14. Pressor and subpressor angiotensin II administration. Two experimental models of hypertension.
Simon G; Abraham G; Cserep G
Am J Hypertens; 1995 Jun; 8(6):645-50. PubMed ID: 7662251
[TBL] [Abstract][Full Text] [Related]
15. Does blockade of the renin angiotensin system affect sympathetic and blood pressure responses to amlodipine in young hypertensive patients?
Ruzicka M; Coletta E; Leenen FH
Am J Hypertens; 2007 Nov; 20(11):1202-8. PubMed ID: 17954368
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure regulation on low and high sodium diets in normotensive members of normotensive or hypertensive families.
Pusterla C; Beretta-Piccoli C; Städler P; Weidmann P; Favre L; Vallotton M
J Hypertens Suppl; 1986 Dec; 4(6):S310-3. PubMed ID: 3475419
[TBL] [Abstract][Full Text] [Related]
17. Influence of angiotensin I, angiontensin II and cocaine on adrenergic vasoconstrictor responses in the dog hindpaw.
Kadowitz PJ; Sweet CS; Brody MJ
J Pharmacol Exp Ther; 1972 Nov; 183(2):275-83. PubMed ID: 4343414
[No Abstract] [Full Text] [Related]
18. Role of renal sympathetic nerves in regulating renovascular responses to angiotensin II in spontaneously hypertensive rats.
Dubinion JH; Mi Z; Jackson EK
J Pharmacol Exp Ther; 2006 Jun; 317(3):1330-6. PubMed ID: 16537795
[TBL] [Abstract][Full Text] [Related]
19. Forearm vasoconstrictor response to ouabain: studies in patients with mild and moderate essential hypertension.
Hulthén UL; Bolli P; Kiowski W; Bühler FR
J Cardiovasc Pharmacol; 1984; 6 Suppl 1():S75-81. PubMed ID: 6204162
[TBL] [Abstract][Full Text] [Related]
20. Leukotriene D4 inhibits cardiovascular responses to sympathetic stimulation, angiotensin and vasopressin in the pithed spontaneously hypertensive rats.
Bayorh MH; Zukowska-Grojec Z; Kopin IJ; Feuerstein G
J Pharmacol Exp Ther; 1984 Oct; 231(1):85-90. PubMed ID: 6491978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
